JPMorgan Chase Financial Co. LLC has announced the pricing of $8,857,000 in uncapped digital barrier notes linked to the performance of the Nasdaq-100 Index, the Russell 2000 Index, and the S&P 500 Index. This issuance is significant as it underscores the company’s commitment to providing innovative investment solutions in the national commercial banking sector.
The notes, which are scheduled to settle on or about October 30, 2026, are designed for investors looking for uncapped, unleveraged exposure to the least performing of the aforementioned indices at maturity. However, they come with specific risk factors, including the potential for investors to lose some or all of their principal amount at maturity.
Background
JPMorgan Chase Financial Co. LLC is a finance subsidiary of JPMorgan Chase & Co., incorporated in Delaware and classified under the Standard Industrial Classification (SIC) code 6021, which pertains to national commercial banks. The company is headquartered at 383 Madison Avenue, New York, NY. This recent filing is part of a series of documents submitted on October 29, 2026, including multiple pricing supplements.
What the Filing Says
The filing indicates that the notes are fully and unconditionally guaranteed by JPMorgan Chase & Co. It states, "Investors should be willing to forgo interest and dividend payments and be willing to lose some or all of their principal amount at maturity." The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial, which means that any payment is subject to the credit risk of both the issuer and the guarantor.
Impact
This offering may attract a range of investors looking for exposure to major stock indices while accepting the associated risks. The notes are structured to appeal to those who are comfortable with the potential for significant fluctuations in their investment value, depending on the performance of the underlying indices.
What's Next
The notes are expected to settle on or about October 30, 2026. Further details regarding the performance and terms of the notes will likely be outlined in subsequent filings or updates from the company.
Read Next
Mirum Pharmaceuticals reports stock sale by former officer
Basswood Financial Fund sells shares of Regional Management Corp.
Basswood Financial Fund Files to Sell Shares in Regional Management
HCA Healthcare Officer Jon M. Foster Files to Sell Shares
Regional Management Corp. Sees Shareholder Stock Sale
Wampler Kira Scherer Reports Stock Transactions for Doximity










